Structures by: Pattabhi V.
Total: 20
C30H46O
C30H46O
Acta Crystallographica Section E (2004) 60, 6 o1092-o1093
a=10.422(4)Å b=13.881(5)Å c=17.591(6)Å
α=90.00° β=90.00° γ=90.00°
Modified amino acid
C42H46N2O6
Acta Crystallographica Section E (2002) 58, 9 o1038-o1039
a=15.890(2)Å b=11.2944(16)Å c=21.125(3)Å
α=90.00° β=90.00° γ=90.00°
Satranidazole
C8H11N5O5S
Acta Crystallographica Section E (2002) 58, 10 o1136-o1138
a=7.046(2)Å b=19.566(6)Å c=8.743(2)Å
α=90.00° β=90.00(2)° γ=90.00°
C15H14O2
C15H14O2
Acta Crystallographica Section C (1992) 48, 11 1980-1981
a=7.7505(9)Å b=16.484(2)Å c=8.7383(9)Å
α=90° β=101.160(10)° γ=90°
C2H10N22,C7H3N2O6,C7H3N2O6
C2H10N22,C7H3N2O6,C7H3N2O6
Acta Crystallographica Section C (1992) 48, 12 2207-2209
a=6.7370(10)Å b=7.803(7)Å c=10.4440(10)Å
α=94.747(8)° β=108.300(10)° γ=97.430(10)°
C21H18O2
C21H18O2
Acta Crystallographica Section C (1994) 50, 4 594-597
a=7.9250(10)Å b=9.281(2)Å c=20.918(3)Å
α=90.° β=90.° γ=90.°
C19H16O2
C19H16O2
Acta Crystallographica Section C (1994) 50, 4 594-597
a=6.2930(10)Å b=28.3480(10)Å c=7.8560(10)Å
α=90.° β=95.290(10)° γ=90.°
4-hydroxy-2-methyl-N-(5-methyl-2-thiazole)-2H-1,2-benzothiazine-3 -carboxamide 1,1-dioxide
C14H13N3O4S2
Acta Crystallographica Section C (1998) 54, 12 2001-2003
a=6.9960(10)Å b=8.1060(10)Å c=13.6020(10)Å
α=85.680(10)° β=88.360(10)° γ=74.880(10)°
1-isobutyl-2,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-3-indoleacetic acid
C17H25NO3
Acta Crystallographica Section C (1999) 55, 1 100-102
a=9.233(5)Å b=12.952(3)Å c=13.943(5)Å
α=90.0(3)° β=105.930(10)° γ=90.0°
C16H14O4
C16H14O4
Acta Crystallographica Section C (1999) 55, 5 813-815
a=7.669(5)Å b=12.402(8)Å c=27.204(7)Å
α=90.00° β=90.00° γ=90.00°
1a,2a-Epoxy-24(R)-acyloxycholesta-4,6-dien-3-one hydrate
C29H42O4,H2O
Acta Crystallographica Section C (2000) 56, 11 e538-e538
a=10.642(3)Å b=11.719(2)Å c=10.977(3)Å
α=90.00° β=108.04(2)° γ=90.00°
6-Acetylamino-6,7-dihydro-5H-dibenzo[a,c]cycloheptene-6-carboxylic acid ethyl ester
C20H21NO3
Acta Crystallographica Section C (2002) 58, 5 o266-o267
a=7.837(2)Å b=24.074(9)Å c=9.543(2)Å
α=90° β=102.87(2)° γ=90°
Ethyl 2-formamido-2-(4-iodobenzyl)-3-(4-iodophenyl)propanoate
C19H19I2NO3
Acta Crystallographica Section C (2003) 59, 4 o216-o218
a=13.982(7)Å b=8.922(5)Å c=16.533(8)Å
α=90.00° β=92.976(8)° γ=90.00°
Ethyl 2-formamido-2-(3-bromobenzyl)-3-(3-bromophenyl)propanoate
C19H19Br2NO3
Acta Crystallographica Section C (2003) 59, 4 o216-o218
a=11.380(3)Å b=14.867(3)Å c=12.525(3)Å
α=90.00° β=110.431(4)° γ=90.00°
(3aR,3bR,4aR,4bS,5aS,8aR,8bR,9aR,9bS,10aS)- perhydrodipentaleno[2,1-a:2',1'-e]pentalene-1,6-dione
C20H26O2
Acta Crystallographica Section C (2003) 59, 7 o373-o375
a=9.415(8)Å b=10.739(2)Å c=15.332(3)Å
α=90.00° β=92.58(4)° γ=90.00°
(2R,2''S,3'bS,4'aR,7'bS,8'aR)-perhydrodispiro[furan-2,3'- dicyclopenta[a,e]pentalene-7',2''-furan]-5,5''-dione
C20H26O4
Acta Crystallographica Section C (2003) 59, 7 o373-o375
a=7.085(3)Å b=12.064(5)Å c=19.583(5)Å
α=90.00° β=91.54(3)° γ=90.00°
Ethyl 2-benzyl-2-(formylamino)-3-phenylpropionate
C19H21NO3
Acta Crystallographica Section C (2004) 60, 7 o527-o530
a=9.980(2)Å b=11.853(3)Å c=14.575(4)Å
α=90.00° β=94.147(4)° γ=90.00°
Ethyl 3-(1,1'-biphenyl-4-yl)-2-(formylamino)-2-(4-phenylbenzyl)propionate
C31H29NO3
Acta Crystallographica Section C (2004) 60, 7 o527-o530
a=26.761(5)Å b=10.9424(19)Å c=8.5818(15)Å
α=90.00° β=95.068(3)° γ=90.00°
1a,2a-Epoxy-24(R)-acyloxycholesta-4,6-dien-3-one hydrate
C29H42O4,H2O
Acta Crystallographica Section C (2000) 56, 7 e307-e308
a=10.642(3)Å b=11.719(2)Å c=10.977(3)Å
α=90.00° β=108.04(2)° γ=90.00°
C33H74N9O12
C33H74N9O12
Journal of the American Chemical Society (1999) 121, 5575-5576
a=28.074(5)Å b=11.287(1)Å c=23.654(3)Å
α=90.00(1)° β=117.10(1)° γ=90.00(1)°